Skip to content

Rapid genomic sequencing for the diagnosis of critically ill children in the NHS Genomic Medicine Service: Ensuring an equitable and effective parent and patient-centred service

Rapid genomic sequencing for the diagnosis of critically ill children in the NHS Genomic Medicine Service: A mixed-methods evaluation to ensure an equitable and effective parent and patient-centred service

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN52590306
Enrollment
230
Registered
2021-09-20
Start date
2021-11-01
Completion date
Unknown
Last updated
2021-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Evaluation of a clinical service offering rapid genomic sequencing for the diagnosis of critically ill babies and children Not Applicable

Interventions

This study is a mixed-methods evaluation of the rapid genomic sequencing service that is offered by the NHS Genomic Medicine Service. The evaluation consists of four sub-studies: 1. Su

Sponsors

Great Ormond Street Hospital for Children NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Parents/carers of children with rare or undiagnosed conditions 2. Parents who have been offered rapid genomic sequencing because their baby or child was critically ill 3. Parents who have been offered rapid genomic sequencing to inform management of a current pregnancy because they had a previously affected undiagnosed fetus/child 4. Professionals from clinical genetics and paediatrics specialties 5. Over 18 years of age 6. Able to give consent for participation

Exclusion criteria

Exclusion criteria: Under 18 years of age

Design outcomes

Primary

MeasureTime frame
Parent attitudes towards rapid genomic sequencing, measured using qualitative interviews and thematic analysis at least 3 months after being offered testing

Secondary

MeasureTime frame
1. Challenges for delivering rapid genomic sequencing in the NHS, measured using qualitative interviews and surveys with professionals conducted within a 12-month period, which will be analysed with thematic analysis and descriptive statistics, respectively 2. Change in clinical management following rapid genomic sequencing, measured using a clinical audit for all patients tested in a 12-month period

Countries

England, United Kingdom

Contacts

Public ContactMelissa Hill
melissa.hill@ucl.ac.uk+44 (0)20 7405 9200/8225

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026